Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Bioton Owners Approve Capital Increase To Fund Biolek Purchase

Oct. 20 (Bloomberg) -- Shareholders of Bioton SA, Poland’s largest biotechnology company, yesterday approved a capital increase of as much as 319.1 million zloty ($100.5 million) through the issue of up to 1.6 billion warrants for Bioton shares to Troqueera Enterprises Limited, the company said in a disclosure statement.

The capital increase will be used to finance acquisition from Troqueera of a 50.1 percent stake in Biolek Sp. z o.o., a maker of veterinary and pharmaceutical products, Bioton’s management board said in a statement. The main reason for the acquisition is a $1.2 billion contract held by Biolek to distribute veterinary products in China from 2012 to 2021, the board said.

Link to Statement:{NSN LTBOWA3PR6RK <GO>}

Link to Company News:{BIO PW <Equity> CN <GO>} Link to Company News:{0066870Z PW <Equity> CN <GO>} Link to Company News:{0066862Z PW <Equity> CN <GO>}

To contact the editor responsible for this story: David McQuaid at dmcquaid1@bloomberg.net

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.